Oral Iron – Once a Day vs. Alternate Day Dosing

Iron Dosing in Iron Deficiency Anemia: An Evolving Approach

Oral iron remains the first-line therapy for iron deficiency anemia, but optimal dosing strategies have shifted in recent years. Traditionally given once or twice daily, iron supplements are now often prescribed every other day based on studies showing improved absorption and reduced side effects with less frequent dosing. This is due to the role of hepcidin, a key regulator of iron absorption, which rises in response to iron intake and suppresses further uptake. By spacing doses, hepcidin levels decline, allowing for better fractional absorption of subsequent doses.¹ Clinicians must balance absorption, tolerability, and adherence when choosing a regimen, and individualization remains key.

Let’s do the Math

Let’s walk through the math of fractional vs. total iron absorption for daily vs. every-other-day (EOD) oral iron dosing using example numbers from real-world data.

Let’s use midpoints for clarity:

• Daily FIA = 12%
• EOD FIA = 24%

Daily Dosing (60 mg x 7 days):

• Total iron given per week: 60 mg×7=420 mg
• Total iron absorbed per week: 420 mg×0.12=50.4 mg

Every-Other-Day Dosing (60 mg x 3.5 doses)

• Total iron given per week: 60 mg×3.5=210 mg
• Total iron absorbed per week: 210 mg×0.24=50.4 mg

Result:

• Total iron absorbed per week is the same in both regimens (50.4 mg/week)
• Fractional absorption is doubled with alternate-day dosing
• Less iron is ingested overall with EOD dosing — which often means fewer side effects (e.g., nausea, constipation)

Primary Studies

• Pasupathy et al, 2023
  • Study Purpose:
    • To determine whether taking oral iron supplements on alternate days (higher dose but less frequent) is more effective than daily lower-dose supplements in raising hemoglobin among adults with iron deficiency anemia.
  • Methods:
    • 200 adults with significant iron deficiency anemia (hemoglobin ≤ 10 g/dL) were randomized to:
      • 120 mg elemental iron on alternate days
      • 60 mg elemental iron daily
      • Duration: 8 weeks
    • Double-blind design, regular follow-ups, monitored for hemoglobin, ferritin, reticulocyte counts, and side effects.
  • Key Results:
    • Both groups had similar increases in hemoglobin over 8 weeks (alternate day: +1.05 g/dL; daily: +1.36 g/dL; p = 0.47), meaning neither strategy was superior in improving anemia.
    • No statistically significant differences in secondary measures (change in ferritin, reticulocyte response, proportion of patients with ≥2 g/dL rise in hemoglobin).
    • Side effects (nausea, GI upset) were similar in both groups; only nausea at 4 weeks was significantly higher in alternate day group.
    • No participant stopped treatment because of adverse effects.
  • Conclusions:
    • There is no significant difference in efficacy between daily and alternate day oral iron in raising hemoglobin or replenishing iron stores.
    • Both regimens are similarly safe and tolerable.
    • The study suggests that concerns about alternate-day dosing leading to inferior anemia correction are not supported, and the scheduling of iron dosing can be flexible based on patient preference and tolerance.
    • Calls for further large, long-term trials to confirm and extend these findings.
  • Clinical Implications:
    • Either daily or alternate day oral iron supplementation is reasonable for treating iron deficiency anemia.
    • The choice can be tailored to individual preferences and tolerability.
  • This is, to date, the largest RCT to compare these two iron supplementation strategies in anemic adults using clinically meaningful outcomes.
• Patel et al, 2024
  • Study Purpose:
    • To examine the effectiveness of daily, multiple daily, and alternate-day oral iron supplementation regimens for treating iron deficiency anemia (IDA) in US veterans, including those with and without chronic kidney disease (CKD).
  • Study Design & Population:
    • Retrospective cohort study of over 71,000 US veterans with IDA, split into groups:
      • Normal kidney function (NKF; 47,201)
      • CKD (24,476)
    • Compared 3 regimens:
      • Daily (once per day)
      • Multiple doses per day
      • Alternate-day dosing
    • Main outcomes: changes in hemoglobin, ferritin, iron saturation, total iron binding capacity over up to 180 days.
  • Key Results:
    • All groups improved: Hemoglobin and iron markers increased with all regimens.
    • Multiple doses per day (MDD) led to the fastest improvement in hemoglobin and iron stores.
      • At 90 days (NKF): MDD group had a 1.38 g/dL hemoglobin rise, daily group 1.03 g/dL, alternate-day group 0.93 g/dL.
      • Similar trends seen in CKD, but overall rises were smaller.
    • No significant difference between daily and alternate-day dosing: Both schedules produced similar improvements in hemoglobin and iron indices; any differences were clinically minor.
    • Patients with CKD: All regimens were less effective for hemoglobin improvement compared to those with normal kidney function, but relative performance of routines was the same.
    • Clinical implication: The choice of regimen should depend on how quickly you want hemoglobin to rise and on patient preference, considering potential side effects.
    • Did not include detailed, patient-level data on the frequency or severity of side effects.
  • Conclusions:
    • All dosing patterns work to treat IDA, but if rapid correction is needed, multiple daily dosing is slightly more effective.
    • Daily and alternate-day dosing are essentially equivalent—either can be chosen based on patient’s needs, side effects, and lifestyle.
    • The findings support individualization of iron therapy and also highlight that alternate-day dosing is not inferior to daily dosing.
  • Bottom Line:
    • For most adults with iron deficiency anemia, daily and alternate-day oral iron supplement routines are equally effective for raising hemoglobin and iron stores, and multiple daily doses work somewhat faster. Personalization based on patient preference and need for speed of response is recommended.
• Stoffel et al, 2017
  • Study Purpose:
    • To compare how much iron is absorbed (bioavailability) when iron is given:
      • On consecutive days vs. alternate days
      • In one dose vs. split into two daily doses
    • Design & Population:
      • Two open-label randomized controlled trials in healthy iron-depleted women (ferritin ≤25 µg/L), ages 18–40, at ETH Zurich (Switzerland).
      • Study 1: 40 women got 60 mg iron either daily for 14 days or on alternate days for 28 days (total iron dose same).
      • Study 2: 20 women got a single 120 mg dose or 60 mg twice daily for 3 days, then switched.
    • Key Findings
      • Alternate-day dosing (Study 1):
        • Led to 34% higher iron absorption than daily dosing (fractional absorption 21.8% vs. 16.3%, p=0.0013; total iron absorbed also significantly higher).
        • Alternate-day group had lower serum hepcidin (a hormone that blocks iron absorption).
      • Splitting the dose (Study 2):
        • No significant difference in absorption between once-daily 120 mg and split 60 mg twice daily dosing.
        • However, split dosing increased serum hepcidin more than once-daily dosing, which could in theory reduce absorption over time.
      • Tolerance/Side Effects:
        • Gastrointestinal side effects (nausea, abdominal pain) were more frequent with daily dosing (but not statistically significant).
        • Most reported adverse effects were mild; there was no evidence of gut inflammation or enterocyte damage (by biomarker testing).
      • Implications:
        • Alternate-day iron (single morning dose) improves absorption in iron-depleted women compared with the same total dose given daily.
        • Splitting the daily dose (morning and evening) does not improve absorption and raises hepcidin higher.
        • Intermittent dosing may also result in better tolerance and possibly better compliance.
      • Bottom Line:
        • For non-anemic or mildly anemic, iron-deficient women, giving oral iron every other day, all at once in the morning, results in substantially better iron absorption than daily dosing, and splitting the dose offers no additional absorption benefit.
    • A 2024 review of 11 studies found that daily dosing more often caused side effects, and most effectiveness outcomes (hemoglobin improvement, ferritin) were equivalent between regimens. Patient tolerance and adherence were often better with non-daily dosing.

Clinical Practice Guidelines

• `American Gastroenterological Association:
  • “Give oral iron once a day at most. Every-other-day iron dosing may be better tolerated for some patients, with similar or equal rates of iron absorption and efficacy as daily dosing. The hemoglobin level should increase after one month of supplementation. Dosing should be individualized based on response and tolerability.”
• British Society of Gastroenterology:
  • “We recommend that the initial treatment of IDA should be with one tablet per day of ferrous sulphate, fumarate or gluconate. If not tolerated, a reduced dose of one tablet every other day, alternative oral preparations or parenteral iron should be considered (evidence quality—medium, consensus—92%, statement strength—strong).”

Conclusion

While alternate-day dosing of oral iron leads to higher fractional absorption due to reduced hepcidin activity, the difference in total iron absorbed compared to daily dosing is relatively small. Some studies suggest that alternate-day therapy is associated with fewer gastrointestinal side effects, though this finding has not been consistent across all trials.

Ultimately, there is no clear superiority of one regimen over the other in terms of efficacy. It is reasonable to engage in a shared decision-making discussion with the patient and tailor the dosing schedule based on tolerability, adherence, and individual preferences.

AI-Generated Podcast/Audio

Click on the audio player below to listen to the AI-generated podcast created in NotebookLM from TBP source material. This version has been reviewed and edited by TBP.